Leila Rahbarnia

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Infection

Probiotics and antimicrobial proteins

Journal of cellular biochemistry

Molecular biotechnology

Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences

Tabriz University of Medical Sciences Drug Applied Research Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences Jul 01 2017

Iran

assistant professor

Education History

Tabriz University of Medical Sciences Drug Applied Research Center Jul 01 2012

Iran

PHD

Publications

Samaneh Jahandar-Lashaki, Safar Farajniya, Aref Faraji-Barhagh, Zahra Hosseini, Nasim Bakhtiyari, Leila Rahbarnia
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update. Molecular biotechnology (2024)
Parisa Mansouri Rad, Leila Rahbarnia, Azam Safary, Azizeh ShadiDizaji, Zahra Maani
The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties. Probiotics and antimicrobial proteins (2023)
Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Amir-Hossein Olfati, Leila Rahbarnia, Azam Safary
Bio-nano scale modifications of melittin for improving therapeutic efficacy. Expert opinion on biological therapy 22 (7) (2022)
Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Leila Rahbarnia, Azam Safary
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection. Infection 50 (2) (2021)
Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 49 (6) (2021)
Vahideh Ahmadzadeh, Habib Zarredar, Roghayyeh Baghban, Leila Rahbarnia, Habib Zarredar
CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond. Journal of cellular biochemistry 120 (10) (2019)
Fatemeh Ravanbakhsh Ghavghani, Leila Rahbarnia, Behrooz Naghili, Alireza Dehnad, Ahad Bazmani, Mojtaba Varshochi, Mohammad Hossein Ghaffari Agdam
Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran. BMC research notes 12 (1) (2019)
Leila Rahbarnia, Safar Farajnia, Behrooz Naghili, Vahideh Ahmadzadeh, Kamal Veisi, Roghayyeh Baghban, Sayna Toraby
Current trends in targeted therapy for drug-resistant infections. Applied microbiology and biotechnology 103 (20) (2019)

Leila Rahbarnia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Leila Rahbarnia